0001630212-23-000003.txt : 20231020 0001630212-23-000003.hdr.sgml : 20231020 20231020161823 ACCESSION NUMBER: 0001630212-23-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231020 DATE AS OF CHANGE: 20231020 EFFECTIVENESS DATE: 20231020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalon GloboCare Corp. CENTRAL INDEX KEY: 0001630212 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471685128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-495339 FILM NUMBER: 231337350 BUSINESS ADDRESS: STREET 1: 4400 ROUTE 9 STREET 2: SUITE 3100 CITY: FREEHOLD STATE: NJ ZIP: 07728 BUSINESS PHONE: 732-780-4400 MAIL ADDRESS: STREET 1: 4400 ROUTE 9 STREET 2: SUITE 3100 CITY: FREEHOLD STATE: NJ ZIP: 07728 FORMER COMPANY: FORMER CONFORMED NAME: Avalon Globocare Corp. DATE OF NAME CHANGE: 20161018 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL TECHNOLOGIES CORP DATE OF NAME CHANGE: 20150108 D 1 primary_doc.xml X0708 D LIVE 0001630212 Avalon GloboCare Corp. 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ NEW JERSEY 07728 732-780-4400 DELAWARE Avalon Globocare Corp. GLOBAL TECHNOLOGIES CORP Corporation true David K Jin 4400 Route 9 South Suite 3100 Freehold NJ NEW JERSEY 07728 Executive Officer Director Chief Executive Officer Luisa Ingargiola 4400 Route 9 South Suite 3100 Freehold NJ NEW JERSEY 07728 Executive Officer Chief Financial Officer Biotechnology $25,000,001 - $100,000,000 06b false 2023-10-09 false true Convertible Debt false 0 Revere Securities LLC 14178 None None 650 FIFTH AVENUE 35FTH FLOOR NEW YORK NY NEW YORK 10019 MA MASSACHUSETTS NY NEW YORK false 700000 700000 0 false 2 53200 0 0 false Avalon GloboCare Corp. /s/ Luisa Ingargolia Luisa Ingargolia Chief Financial Officer 2023-10-20